Bayer Corporation Starts Phase III Study of Lung Drug Riociguat
FRANKFURT, Feb 9 (Reuters) - Bayer AG has entered phase III of testing its experimental pulmonary-hypertension drug riociguat after the pill showed promise in an earlier trial, the company said on Monday.